# UNIVERSITY OF PENNSYLVANIA: Targeting metabolic drivers of therapy resistance in TP53 mutant acute myeloid leukemia

**Lab Budget Score:** 25/100

| Field | Value |
|---|---|
| Organization | UNIVERSITY OF PENNSYLVANIA |
| Location | PHILADELPHIA, PA |
| Project | Targeting metabolic drivers of therapy resistance in TP53 mutant acute myeloid leukemia |
| Project number | 1K08CA297049-01A1 |
| Mechanism | K08 |
| Institute | National Cancer Institute |
| Award | $298,701 |
| Awarded | 2026-09-17 |
| Project period | 2026-09-18 to 2031-08-31 |
| UEI | GM1XX56LEP58 |

## Why this score
- Award of $298,701.

Source: NIH RePORTER (newly awarded projects) (https://reporter.nih.gov/project-details/11302262). Last refreshed: 2026-11-03T18:16:24.961Z.
Award data comes from NIH RePORTER and may be revised by NIH. Organization-level only; investigator names and contacts are not included. Informational only.
